Search Results - "Mark S. Cooper"

Refine Results
  1. 1

    Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases by Hardy, Rowan S., Raza, Karim, Cooper, Mark S.

    Published in Nature reviews. Rheumatology (01-03-2020)
    “…Therapeutic glucocorticoids have been widely used in rheumatic diseases since they became available over 60 years ago. Despite the advent of more specific…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Glucocorticoid-Induced Psychosis in Children and Adolescents: A Systematic Review by Fani-Molky, Parisa, Bradley, Jarrod, Cooper, Mark S

    “…Knowledge is limited regarding the adverse effects of therapeutic glucocorticoids on pediatric mental health outcomes. Glucocorticoid-induced psychosis (GIP)…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives by Seibel, Markus J, Prof, Cooper, Mark S, Prof, Zhou, Hong, MD

    Published in The lancet. Diabetes & endocrinology (01-09-2013)
    “…Summary Glucocorticoids are widely used for their unsurpassed anti-inflammatory and immunomodulatory effects. However, the therapeutic use of glucocorticoids…”
    Get full text
    Journal Article
  7. 7

    Corticosteroid Insufficiency in Acutely Ill Patients by Cooper, Mark S, Stewart, Paul M

    Published in The New England journal of medicine (20-02-2003)
    “…Recent studies report benefits from corticosteroid treatment in patients with septic shock. This review summarizes the physiology of the corticosteroid…”
    Get full text
    Journal Article
  8. 8

    Association between bone mineral density and C-reactive protein in a large population-based sample by de Pablo, Paola, Cooper, Mark S., Buckley, Christopher D.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-08-2012)
    “…Objective Several studies suggest that bone mineral density (BMD) is reduced in chronic inflammatory diseases. Higher serum levels of C‐reactive protein (CRP)…”
    Get full text
    Journal Article
  9. 9

    Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe by Martin, Claire S, Cooper, Mark S, Hardy, Rowan S

    Published in Frontiers in endocrinology (Lausanne) (27-08-2021)
    “…The role of tissue specific metabolism of endogenous glucocorticoids (GCs) in the pathogenesis of human disease has been a field of intense interest over the…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis by Webster, Justine M, Sagmeister, Michael S, Fenton, Chloe G, Seabright, Alex P, Lai, Yu-Chiang, Jones, Simon W, Filer, Andrew, Cooper, Mark S, Lavery, Gareth G, Raza, Karim, Langen, Ramon, Hardy, Rowan S

    “…Glucocorticoids provide indispensable anti-inflammatory therapies. However, metabolic adverse effects including muscle wasting restrict their use. The enzyme…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma by Bosnakovski, Darko, Ener, Elizabeth T., Cooper, Mark S., Gearhart, Micah D., Knights, Kevin A., Xu, Natalie C., Palumbo, Christian A., Toso, Erik A., Marsh, Graham P., Maple, Hannah J., Kyba, Michael

    Published in Oncogenesis (New York, NY) (12-10-2021)
    “…CIC-DUX4 sarcoma (CDS) is a highly aggressive and metastatic small round type of predominantly pediatric sarcoma driven by a fusion oncoprotein comprising the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Glucocorticoid metabolism in rheumatoid arthritis by Hardy, Rowan S., Raza, Karim, Cooper, Mark S.

    Published in Annals of the New York Academy of Sciences (01-05-2014)
    “…Endogenous glucocorticoids are implicated in the development and resolution of inflammation. Until recently it was thought that these glucocorticoids arose…”
    Get full text
    Journal Article
  16. 16

    Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy by Hardy, Rowan S, Zhou, Hong, Seibel, Markus J, Cooper, Mark S

    Published in Endocrine reviews (01-10-2018)
    “…Osteoporosis associated with long-term glucocorticoid therapy remains a common and serious bone disease. Additionally, in recent years it has become clear that…”
    Get full text
    Journal Article
  17. 17

    Glucocorticoids in bone and joint disease: the good, the bad and the uncertain by Cooper, Mark S.

    Published in Clinical medicine (London, England) (01-06-2012)
    “…Therapeutic glucocorticoids are widely used to treat a variety of inflammatory conditions. However, the beneficial anti-inflammatory effects of glucocorticoids…”
    Get full text
    Journal Article
  18. 18

    Disorders of calcium metabolism and parathyroid disease by Cooper, Mark S., BA, BMBCh, MRCP, PhD

    “…Pregnancy and lactation are associated with profound changes in calcium physiology. This can make interpretation of biochemical tests difficult during these…”
    Get full text
    Journal Article
  19. 19

    Sensitivity of bone to glucocorticoids by Cooper, Mark S

    Published in Clinical science (1979) (01-08-2004)
    “…Glucocorticoids are used widely in a range of medical specialities, but their main limitation is an adverse impact on bone. Although physicians are…”
    Get more information
    Journal Article
  20. 20

    Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice by Henneicke, Holger, Kim, Sarah, Swarbrick, Michael M., Li, Jingbao, Gasparini, Sylvia J., Thai, Joanne, Foong, Daphne, Cavanagh, Lauryn L., Fong-Yee, Colette, Karsten, Elisabeth, Lin, Ruby C.Y., Cooper, Mark S., Zhou, Hong, Seibel, Markus J.

    Published in Molecular metabolism (Germany) (01-12-2020)
    “…Aging and chronic glucocorticoid excess share a number of critical features, including the development of central obesity, insulin resistance and osteoporosis…”
    Get full text
    Journal Article